-
IntroducedJan 22, 2026
-
Passed House
-
Passed Senate
-
Became Law
Tennessee House Bill
Controlled Substances - As introduced, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
Last Action See all actions
House • Feb 11, 2026: Placed on s/c cal Health Subcommittee for 2/18/2026
Latest Bill Text See all bill texts
Summary
Comments on HB 1984
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 11, 2026 | House
- Sponsor change.
- Sponsor(s) withdrawn.
- Placed on s/c cal Health Subcommittee for 2/18/2026
- Feb 04, 2026 | House
- P2C, ref. to Health Committee
- Assigned to s/c Health Subcommittee
- Feb 02, 2026 | House
- Intro., P1C.
- Jan 22, 2026 | House
- Filed for introduction
Bill Texts
Documents

